ArticleDiscover oncology2024

Interventional therapy combined with tyrosine kinase inhibitors with or without immune checkpoint inhibitors as initial treatment for hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis.

Changjie Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.